Side-by-side comparison of AI visibility scores, market position, and capabilities
Indianapolis largest US retail REIT (NYSE: SPG) at record $4.9B 2024 FFO; 96.5% occupancy (8-year high), $6.16B revenue, 232 properties/200M sq ft with Premium Outlets network competing with Macerich for luxury retail tenants.
Simon Property Group, Inc. is an Indianapolis, Indiana-based retail real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: SPG) as an S&P 500 REIT component — owning or holding interests in 232 properties across 37 states and Puerto Rico plus 35 international properties, comprising 92 malls, 70 Premium Outlets, 14 Mills, 6 lifestyle centers, and 12 other retail properties totaling approximately 200 million square feet of retail space. In fiscal year 2024, Simon Property Group reported record total funds from operations (FFO) of $4.9 billion ($12.99 per share), trailing twelve-month revenue of $6.16 billion, domestic net operating income (NOI) growth of 4.7%, and portfolio occupancy of 96.5% — the highest in eight years — while signing a record 5,500 leases covering 21+ million square feet, with base minimum rent per square foot increasing 2.5% to $58.26. CEO David Simon (son of founder Melvin Simon, CEO since 1995, Chairman since 2007) has led the company through the pandemic retail disruption and the subsequent mall resurgence, emphasizing the "shop, eat, stay and play" mixed-use destination strategy. Founded in 1960 by Melvin Simon with two small strip malls near Indianapolis, Simon became the largest US REIT IPO in history at its $840 million IPO in 1993 and built its portfolio through acquisitions of DeBartolo Realty (1996), Chelsea Property Group ($3.5B, 2004), Mills Corporation (2007), and Taubman Centers ($3.4B, 2020).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.